- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01986686
Recurrence Following Nonoperative Management of 1st Episode of Hinchey II Diverticulitis
May 26, 2017 updated by: Stony Brook University
Should Elective Resection Follow Nonoperative Management of First Episode of Diverticulitis of the Colon With Abscess and/or Extraluminal Air? A Randomized Controlled Trial.
Patients will agree to be randomized to either surgery or observation following nonoperative management of a first episode of Hinchey II diverticulitis.
Information will be collected on recurrence rates and major complications in both groups.
Study Overview
Detailed Description
This study will randomize patients with first episode of acute diverticulitis of the colon with extraluminal air and/or abscess as defined by CT scan following nonoperative management (NPO, IV antibiotics, percutaneous drainage, and TPN followed by colonoscopy) to observation or elective resection.
The primary endpoint is recurrent diverticulitis of the colon defined as an acute episode confirmed at CT scan and requiring hospitalization with IV antibiotics.
Study Type
Interventional
Enrollment (Actual)
107
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Stony Brook, New York, United States, 11794
- Stony Brook Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- older than or equal to 18
- history of resolved first episode of diverticulitis with abscess (Hinchey class II) who were successfully treated by our standard protocol
- the diagnosis confirmed by colonoscopy
- Signed informed consent
Exclusion Criteria:
- Prior episode of diverticulitis
- Right sided diverticulitis
- Failure of recovery from first episode, defined as recurrence within one month.
- Cancer found at the site on screening colonoscopy
- Comorbidities prohibiting surgery (as measured by colorectal POSSUM score)
- Immunosuppressed patients
- Hinchey I, III, or IV (diverticulitis with peritonitis and/or free air under the diaphragm)
- Patients who are unable to sign the informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Observational
The observation group will be followed clinically with no further intervention until the primary endpoint is reached.
|
|
Active Comparator: Surgery
The surgery group will be offered colon resection.
|
Elective robotic/laparoscopic/open colon resection for diverticular disease.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Primary Study Endpoint
Time Frame: Minimum of 1 year after enrollment
|
The primary outcome measure is recurrent diverticulitis of the colon defined as an acute episode confirmed at CT scan and requiring hospitalization with IV antibiotics.
|
Minimum of 1 year after enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measure Length of Hospital Stay for Surgery vs Non Surgery Patients
Time Frame: 4 years
|
Data collected will include length of hospital stay from the date of admission to discharge day for nonoperative management of the first episode of Hinchey II diverticulitis.
|
4 years
|
Mortality
Time Frame: 4 years
|
Data will be collected on percent of patients who die during the follow-up period after enrollment.
|
4 years
|
Readmission
Time Frame: 30 days
|
Data will be collected on percent of patients who are readmitted for recurrence or postoperative complications during the follow-up period after enrollment.
|
30 days
|
Post Operative Complications
Time Frame: 30 days
|
Data will be collected on percent and type of complications for the surgery arm.
|
30 days
|
Recurrence and Treatment
Time Frame: 2 years
|
Data will be collected on recurrence and treatment for recurrent diverticulitis
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2011
Primary Completion (Actual)
July 16, 2016
Study Completion (Actual)
July 16, 2016
Study Registration Dates
First Submitted
August 9, 2013
First Submitted That Met QC Criteria
November 11, 2013
First Posted (Estimate)
November 18, 2013
Study Record Updates
Last Update Posted (Actual)
October 18, 2017
Last Update Submitted That Met QC Criteria
May 26, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RCB1956
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diverticulitis
-
Hospital Central de la Defensa Gómez UllaCompletedDiverticulitis | Diverticulitis Colon | Diverticulitis of Sigmoid | Diverticulitis; Perforation, BowelSpain
-
Sebastiano BiondoRecruiting
-
University of AarhusOdense University Hospital; Aarhus University Hospital; University of Southern... and other collaboratorsRecruiting
-
Ente Ospedaliero Ospedali GallieraCompletedPeritonitis Caused by Perforated Left-sided Colon DiverticulitisItaly
-
Tepecik Training and Research HospitalCompleted
-
Sealantis Ltd.WithdrawnColorectal Cancer | Diverticulitis Colon
-
Uppsala UniversityCompletedColonic DiverticulitisSweden
-
Uppsala UniversityLandstinget i VärmlandCompleted
-
Hospital General Universitario Reina Sofía de MurciaCompletedDiet Modification | Diverticulitis | Dietary Modification | Diverticulitis, Colonic | Acute Diverticulitis | Uncomplicated Diverticular Disease | Diverticulitis of SigmoidSpain
-
Uppsala UniversitySahlgrenska University Hospital, Sweden; University Hospital, Linkoeping; Danderyd... and other collaboratorsRecruiting
Clinical Trials on Colon resection
-
Russian Society of Colorectal SurgeonsI.M. Sechenov First Moscow State Medical University; G.V. Bondar Republican...Recruiting
-
Ostfold Hospital TrustCompletedColon Cancer | Benign Colon DiseasesNorway
-
Nordsjaellands HospitalHvidovre University Hospital; Bispebjerg Hospital; Herlev and Gentofte HospitalCompletedColon Cancer | Deep Vein Thrombosis, Pulmonary Embolus
-
Hospital General Universitario de AlicanteCompleted
-
Sahlgrenska University Hospital, SwedenCompletedPerforated DiverticulitisSweden
-
Ethicon Endo-SurgeryCompletedLeft-sided Colon ResectionUnited States, United Kingdom, Belgium, Germany, Spain
-
Rabin Medical CenterCompletedAnastomotic LeakIsrael
-
Oslo University HospitalCompletedRegulation of Inflammatory ResponseNorway
-
State Scientific Centre of Coloproctology, Russian...RecruitingColorectal Neoplasms, BenignRussian Federation
-
Santiago R. Leal-NovalInstituto de Salud Carlos IIIUnknownGlioma | Surgery | Coagulopathy | Acquired Platelet Function Disorder | ThromboelastometrySpain